Apply to this 15-month accelerator program tailored to early-stage healthcare projects and you might receive a grant of up to CHF 250,000 (approx. $250,000 USD), industry access, state-of-the-art infrastructure, and support from global biopharmaceutical companies and innovation champions Novartis Venture Fund, Johnson & Johnson Innovation and Pfizer. Basel, Switzerland has one of the most dynamic biotech and pharma ecosystems in Europe.

Register your interest in the next session by June 15, 2017 and follow Lootstrap on Facebook for updates!

Award Amount

  • Up to CHF 250,000 (approx. $250,000 USD)


  • Basel, Switzerland


  • Phase I: 12 weeks
  • Phase II: 12 months

Additional Benefits

  • Work closely with BaseLaunch team and network of experts
  • Extensive network of entrepreneurs-in-residence, advisors and consultants
  • Support from Novartis Venture Fund, Johnson & Johnson Innovation and Pfizer
  • Free office space and ready-to-use labs at the Switzerland Innovation Park Basel Area
  • Active business angel community experienced in the pharma and biotech industry
  • Help with raising non-dilutive funding from foundations and government grants
  • Facilitation of contacts to business angels, venture funds, and family offices

Who Can Apply

  • Individuals or teams
  • Breakthrough healthcare innovations focused on therapeutics preferred
  • Game-changing innovations in diagnostics, medtech or related fields also accepted
  • Startups in the pre-seed to seed funding stage that meet one of the following criteria:
    • On the verge of incorporation
    • Clear plans to secure an Intellectual Property (IP) position or develop a prototype
  • Professors and group leaders with a promising discovery or valuable IP
  • Startups that have already received their series ‘A’ round are accepted
  • International teams welcome but must establish in Basel during Phase II
  • English speaking (program held in English)

Selection Criteria

  • Solid scientific concepts
  • Initial development plan
  • Realistic business case
  • Strong commitment from the project team

Application Process

  • Register your interest by the deadline
  • Preliminary applications evaluated by the BaseLaunch team
  • Invitations to apply are sent out—if invited, you must apply by the deadline
  • Full applications reviewed by the Selection Committee
  • 10 teams selected for Phase I
  • At the end of Phase I, startups will present to the Selection Committee
  • 3 teams with the best presentations will be invited to attend Phase II


  • Teams must participate in activities such as working sessions and presentations
  • Project name, focus area, and description may be used for marketing purposes
  • Phase I startups:
    • Are encouraged to be physically present in Basel
    • Must formulate/refine business case for presentation to Selection Committee
  • Phase II startups must be:
    • Physically present, at least partially, in Basel
    • Incorporated or legally registered in Basel

Post-Program Perks